Skip to Content

WATSON 3359 WATSON 3359 (Tacrolimus 5 mg)

Pill with imprint WATSON 3359 WATSON 3359 is Pink, Capsule-shape and has been identified as Tacrolimus 5 mg. It is supplied by Watson Laboratories, Inc..

Tacrolimus is used in the treatment of nephrotic syndrome; organ transplant, rejection reversal; organ transplant, rejection prophylaxis; crohn's disease; graft-versus-host disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 3359 WATSON 3359

Tacrolimus

Imprint:
WATSON 3359 WATSON 3359
Strength:
5 mg
Color:
Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Calcineurin inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Laboratories, Inc.
Inactive Ingredients:
lactose anhydrous
croscarmellose sodium
hypromelloses
magnesium stearate
gelatin
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
FD&C Red No. 40
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide